Vaccines | Free Full-Text | The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration
Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination | Microbiology Spectrum
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies - eBioMedicine
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern | mBio
Immune imprinting and SARS-CoV-2 vaccine design: Trends in Immunology
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
Should I get my COVID vaccine booster? Yes, it increases protection against COVID, including Omicron
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine
Those Who Had COVID-19 May Only Need One Dose of Vaccine | Penn Medicine
Boosting immunity to Omicron | Nature Medicine
Moderna booster increases antibodies against Omicron
Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination | Cell Discovery
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses - ScienceDirect
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine - ScienceDirect
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine
Chart Shows How Fast COVID Booster Shot Protection Kicks in
SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster - The Lancet Infectious Diseases
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response | Annals of the Rheumatic Diseases
3. Who benefits from vaccines? | Australian Academy of Science
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect
CDC Library: COVID-19 Science Update: 09/10/2021
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
